Somatic and skeleton development of rat foetuses following in-utero exposure to isopropylantipyrine [propyphenazone] during the second trimester of gestation

• Autorzy: Burdan F
• Języki publikacji: EN

Abstrakty

EN

Isopropylantipyrine (IPA, propyphenazone) is a pyrazolone derivative, widely used as an antipyretic and analgesic drug. The aim of the study was to evaluate the influence of propyphenazone on rat development. IPA was administered to pregnant rats from day 8 to day 14 of pregnancy once a day, orally by a stomach tube at doses of 2.10 (R1), 21.0 (R2), and 210.0 mg/kg/day (R3). The dams were sacrificed on day 21 of gestation and corpora luteum, implants, resorptions, and live foetuses were counted. The weight of foetuses and placentas, the length of foetuses and their tails were checked. The foetuses were fixed in alcohol and skeletons were stained with alizarin. There was a statistical difference in body length in R1, R2 and numbers of subcutaneous ecchymose in R1. External and skeletal examination of the foetuses revealed no evidence of teratogenesis. It can be concluded that IPA has no harmful effects on the prenatal development of the rat offspring at doses used in the present study.

Słowa kluczowe

EN

pregnancy; isopropylantipyrine; propyphenazone; development; skeleton; teratogen; gestation; rat

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2000
• Tom: 59
• Numer: 4
• Opis fizyczny: p.317-322,fig.

Twórcy

autor

Burdan F

• Medical University School of Lublin, Spokojna 1, 20-074 Lublin, Poland

Bibliografia

• 1. Burdan F (2000) Ocena bezpieczeństwa stosowania bezrecepturowych, nieopioidowych analgetyków i kofeiny w czasie laktacji. Ped Pol, 75: 425–429.
• 2. Burdan F (2000) Evaluation of bone formation in fetal skeletons following prenatal paracetamol administration in single alizarin-stained specimens in Wistar rats. Folia Morphol, 59: 167–171.
• 3. Burdan F (2001) Teratologia, 40 lat po tragedii talidomidowej. Gin Pol (in press).
• 4. Burdan F, Madej B, Wójtowicz Z, Maciejewski R, Radzikowska E (2000) The effects of short-time caffeine administration on skeleton development in Wistar rats. Folia Morphol, 59: 91–95.
• 5. Burdan F, Wyskiel M (1999) Embryotoxic effect of low doses of caffeine. Ann UMCS Sectio D, 54: 69–73.
• 6. Expert Committee on Teratogenicity Testing and Evaluation (1974) Evaluation of drugs and their chemical agents for teratogencity. Bulletin der Schweizerischen Akademie der Medizinichen Wissenschaften (Supp) 30: 5–62.
• 7. Juszkiewicz T (1982) Działanie toksyczne i teratogenne. In: Rump S, Kleinrok Z (eds) Farmakoterapia — doświadczalne metody badań leków. PZWL, Warszawa, 151–159.
• 8. Kunovits G (1996) Product monograph propyhenazone (Isopropylantipyrine). In: Saridon Tablets, Ro 11–6655/002 Summary product characteristic. Hoffman-La Roche Press, 1–36.
• 9. Manson JM, Kang YJ (1994) Test methods for assessing female reproductive and development toxicology. In: Hayes AW (ed.). Principles and methods of toxicology 3rd edition. Raven Press, New York, 989–1038.
• 10. McBride WG (1961) Thalidomide and congenital abnormalities. Lancet 2: 1358–1361.
• 11. Prescott LF (1996) The metabolism of paracetamol. In: Paracetamol (Acetaminophen). A critical bibliographic review. Taylor&Francis London, 67–99.
• 12. Rashed MS, Nelson SD (1989) Characterization of glutathione conjugates of reactive metabolites of 3’-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen. Chem Res Toxicol, 2: 41–45.
• 13. Scialli AR (1995) Teratology. In: Craighead JE (ed) Pathology of environmental and occupational disease. Mosby, St. Louis, 573–588.
• 14. Shein-Chung C, Jen-Pei L (eds) (1998) Design and analysis of animal studies in pharmaceutical development. Marcel Dekker Inc., New York, Basel, Hong Kong.
• 15. Tateishi M, Koitabashi C, Ichihara S (1980) New metabolites of isopropulantipyrine in the rat. Biochem Pharmacol, 29: 2705–2708.
• 16. Thiersch JB, Phillips FS (1950) Effect of 4-amino pteroylglutamic acid (aminopterin) on early pregnancy. Proc Soc Exp Biol Med, 74: 204–206.
• 17. Wilson JG (1965) Methods for administering agents and detecting malformations in experimental animals. In: Warkany J (ed.): Teratology. Principles and Techniques. University of Chicago Press, Chicago, 261–277.
• 18. World Health Organization Technical Report Series No. 364. (1967) Principles for the testing of drugs for teratogenicity. Report of a WHO Scientific Group. World Health Organization Press, Geneva.